Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company known for developing life-transforming medicines, has announced a collaboration with TriNetX to expand its access to de-identified electronics health records (EHRs).
Regeneron Partners With TriNetX For Access To 300 Million De-Identified Electronic Health Records
